share_log

Summit Therapeutics(SMMT.US)Dhingra Ankur增持10万股普通股股份,价值约37.5万美元

Summit Therapeutics(SMMT.US) Officer Buys US$375K in Common Stock

Futu News ·  Mar 28 09:08

$Summit Therapeutics (SMMT.US)$ Officer Dhingra Ankur purchased 100K shares of Common Stock on Mar 26, 2024 at an average price of $3.75 for a total value of $375K.

1711588115175915267.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment